Forus

Name: Forus
Brand: Forus
Rating: 4.7 (5 reviews)

AI NativeLeader

Accelerating medicine for the people who need it, prescribe it, and create it.

Est 2023|Valuation $3B|Raised $197.4M|12 Ref Customers

LinkedIn 18K|Web traffic 33K|FTEs 39|HQ New York, New York, US

01Competitive Landscape

| Aspect | Forus | CoverMyMeds | Surescripts ePA / PA Portal | |---|---|---|---| | Starting Price | Vendor states no direct charge to providers/patients | Vendor states no direct charge to providers/pharmacists | Vendor provides free PA portal access for prescribers/staff | | Primary Use Case | Workflow automation layer that performs multiple operational tasks on behalf of providers (PA submission, appeals, routing, affordability assistance, patient updates) | Broad ePA initiation/management with extensive industry adoption and pharmacy/payer connectivity | e-prescribing network role and PA portal capabilities; provider of infrastructure used by many EHRs and pharmacies | | Key Strength | Operational handling across several PA-related tasks and inclusion of human oversight in select steps (per vendor) | Established ePA infrastructure and wide adoption across pharmacies and payers | Central role in electronic prescribing and expanding automation initiatives across the network | | Key Weakness | Limited independent reviews in public forums; funding and monetization model creates diligence questions; integration and technical details are not fully disclosed publicly | Community-reported issues exist (implementation variability, payer mapping challenges) | Issue resolution and vendor support can be mediated by EHR/pharmacy software vendors, adding complexity | - Narrative analysis - Incumbent rails vs. a workflow layer - CoverMyMeds and Surescripts are embedded in widely used ePA infrastructures and are typically available as default options inside many EHRs. - The vendor positions Forus as a workflow automation layer that executes multiple operational tasks on behalf of providers, rather than solely submitting ePA forms. - Feature comparison - Forus differentiates itself by offering capabilities beyond ePA initiation, such as appeals letter generation, pharmacy routing, affordability enrollments, and patient communications, as described in vendor materials. - Incumbent vendors may lead on standardization, network reach, and documented integration pathways. - Pricing comparison - All three vendors publicly state they offer free access to prescribers/providers; procurement considerations therefore shift to data usage, routing incentives, and contract terms. - Adoption trends - Vendor materials and press coverage report strong provider adoption; independent third-party review coverage is limited in accessible sources.

01Competitive Landscape

Aspect	Forus	CoverMyMeds	Surescripts ePA / PA Portal
Starting Price	Vendor states no direct charge to providers/patients	Vendor states no direct charge to providers/pharmacists	Vendor provides free PA portal access for prescribers/staff
Primary Use Case	Workflow automation layer that performs multiple operational tasks on behalf of providers (PA submission, appeals, routing, affordability assistance, patient updates)	Broad ePA initiation/management with extensive industry adoption and pharmacy/payer connectivity	e-prescribing network role and PA portal capabilities; provider of infrastructure used by many EHRs and pharmacies
Key Strength	Operational handling across several PA-related tasks and inclusion of human oversight in select steps (per vendor)	Established ePA infrastructure and wide adoption across pharmacies and payers	Central role in electronic prescribing and expanding automation initiatives across the network
Key Weakness	Limited independent reviews in public forums; funding and monetization model creates diligence questions; integration and technical details are not fully disclosed publicly	Community-reported issues exist (implementation variability, payer mapping challenges)	Issue resolution and vendor support can be mediated by EHR/pharmacy software vendors, adding complexity

Narrative analysis
- Incumbent rails vs. a workflow layer
  - CoverMyMeds and Surescripts are embedded in widely used ePA infrastructures and are typically available as default options inside many EHRs.
  - The vendor positions Forus as a workflow automation layer that executes multiple operational tasks on behalf of providers, rather than solely submitting ePA forms.
- Feature comparison
  - Forus differentiates itself by offering capabilities beyond ePA initiation, such as appeals letter generation, pharmacy routing, affordability enrollments, and patient communications, as described in vendor materials.
  - Incumbent vendors may lead on standardization, network reach, and documented integration pathways.
- Pricing comparison
  - All three vendors publicly state they offer free access to prescribers/providers; procurement considerations therefore shift to data usage, routing incentives, and contract terms.
- Adoption trends
  - Vendor materials and press coverage report strong provider adoption; independent third-party review coverage is limited in accessible sources.

Aspect

Forus

CoverMyMeds

Surescripts ePA / PA Portal

Starting Price

Vendor states no direct charge to providers/patients

Vendor states no direct charge to providers/pharmacists

Vendor provides free PA portal access for prescribers/staff

Primary Use Case

Workflow automation layer that performs multiple operational tasks on behalf of providers (PA submission, appeals, routing, affordability assistance, patient updates)

Broad ePA initiation/management with extensive industry adoption and pharmacy/payer connectivity

e-prescribing network role and PA portal capabilities; provider of infrastructure used by many EHRs and pharmacies

Key Strength

Operational handling across several PA-related tasks and inclusion of human oversight in select steps (per vendor)

Established ePA infrastructure and wide adoption across pharmacies and payers

Central role in electronic prescribing and expanding automation initiatives across the network

Key Weakness

Limited independent reviews in public forums; funding and monetization model creates diligence questions; integration and technical details are not fully disclosed publicly

Community-reported issues exist (implementation variability, payer mapping challenges)

Issue resolution and vendor support can be mediated by EHR/pharmacy software vendors, adding complexity

Forus

01Competitive Landscape

02Market Map

01Competitive Landscape

02Market Map